Maurice S. Smith - 28 Mar 2025 Form 4 Insider Report for HALLIBURTON CO (HAL)

Role
Director
Signature
/s/ Sarah I. Rubenfeld, by Power of Attorney
Issuer symbol
HAL
Transactions as of
28 Mar 2025
Net transactions value
$0
Form type
4
Filing time
01 Apr 2025, 17:13:27 UTC
Previous filing
16 Jan 2025
Next filing
02 Apr 2025

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HAL Stock Equivalent Units Award +1,345 +18% 8,704 28 Mar 2025 Common Stock 1,345 Direct F1, F2, F3, F4
holding HAL 12/2024 Restricted Stock Units 6,132 28 Mar 2025 Common Stock 6,132 Direct F5, F6, F7
holding HAL 12/2023 Restricted Stock Units 4,964 28 Mar 2025 Common Stock 4,964 Direct F5, F6, F7
holding HAL 03/2023 Restricted Stock Units 3,967 28 Mar 2025 Common Stock 3,967 Direct F5, F6, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The security converts to common stock on a one-for-one basis.
F2 Stock equivalents acquired under the Halliburton Company Directors' Deferred Compensation Plan reported on a pro-rata basis to reflect Issuer's Plan quarter. Said Plan is an ongoing securities acquisition plan.
F3 The stock equivalent units were accrued under the Company's Directors' Deferred Compensation Plan and are settled in the Company's common stock following cessation as a director.
F4 A portion of the stock equivalents are attributable to quarterly dividends and a portion are attributable to quarterly fees and are based on the closing price on March 26, 2025 of $25.70 and March 28, 2025 of $25.07.
F5 Each restricted stock unit represents a right to receive one share of the Company common stock.
F6 The restricted stock units vest in one year on the first anniversary of the award. Shares will be delivered to the reporting person either upon vesting, or if reporting person elected to defer receipt, following cessation as a director.
F7 Includes stock equivalent units through March 30, 2024.